Muscle Energy Techniques in COPD Patients

NCT04773860 | Unknown DMC

• 1 other identifier: 333797
• Study Type: interventional
• Target: 110
• Locations: 0 countries
• Sites: N/A

Brief Summary

Patients diagnosed with COPD as a result of hyperinflation adapt to the increased workload through shortening and overactivation of other muscles because of their dual function as muscles of the upper limb and neck motion which makes them limited in function and decreases the range of motion in these joints. Another resultant effect of these changes is the shortness of breath taking place following the inability of patients to perform daily activities. Current research is focusing on the use of Muscle Energy Techniques (METs) for such circumstances. Therefore, this study aims to evaluate whether METs result in an improvement in rib cage mobility which could potentially lead to improvements in pulmonary function and activities of daily of living (ADLs) in a group of patients diagnosed with COPD. If positive results are obtained, such an intervention might provide a possible addition to the evidence-based interventions already available for COPD patients. The result of this intervention may provide physiotherapists with further techniques for use in such patients; ones which will be of benefit to the patients and their quality of life and also to the health services.

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD; METs; Muscle Energy Techniques; Dyspnoea; Activities of daily living

Outcome Measures

Primary Outcomes (4)

• Change in Lung function test

  Spirometry

  Week 0, Week 4 and Week 8

• Change in Chest expansion

  Chest expansion using a tape measure

  Week 0, Week 4 and Week 8

• Change in 6 Minute Walk Test

  An endurance test over a 6 minute time frame using a 30m course

  Week 0, Week 4 and Week 8

• Change in Manchester Related Activities of Daily Living Questionnaire

  MR-ADL is a reliable physical disability scale. It is a self-completed scale and usually takes around 10 minutes to complete. It assesses functional ability in 4 different domains, that is in the kitchen, mobility, domestic tasks and leisure activities

  Week 0, Week 4 and Week 8

Study Arms (2)

Experimental

EXPERIMENTAL

The experimental group shall be receiving a 4 week programme of Muscle Energy Techniques on the following accessory muscles; Sternocleidomastoid, Pectoralis Minor, Trapezius, Scalene muscles and Latissimus Dorsi

Other: Muscle Energy Techniques

Control group

NO INTERVENTION

The control group will be taking their prescribed medication and continue with any conventional physiotherapy recommended for the individual.

Interventions

Muscle Energy Techniques OTHER

A 4 week intervention will be carried out consisting of Muscle Energy Techniques on the accessory muscle of respiration. That is, Pectoralis Minor, Sternocleidomastoid, Upper trapezius, Scalene muscles and Latissimus Dorsi

Experimental

Eligibility Criteria

• Age: 40 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• The patient has to have been diagnosed as suffering from COPD by a medical consultant,
• Be medically stable with no exacerbations within the past 2 months and,
• Be between the age range of 40 to 79 years of age.

You may not qualify if:

• Rheumatoid arthritis,
• Musculoskeletal or neuromuscular pathology and,
• Cognitive disability that could affect comprehension or execution of the intervention protocol or outcome measurements

Sponsors & Collaborators

• University of Malta: lead

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive; Dyspnea

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Respiration Disorders; Signs and Symptoms, Respiratory; Signs and Symptoms

Central Study Contacts

Kimberley Sevasta, BSc

CONTACT

79980164; sevastakimberley@gmail.com

Anabel Sciriha, PhD

CONTACT

99423327; anabel.sciriha@um.edu.mt

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Masking Details: Patients shall be randomly assigned to the intervention and control group.
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Model Details: Patients diagnosed with COPD

Study Record Dates

• First Submitted: February 23, 2021
• First Posted: February 26, 2021
• Study Start: February 23, 2021
• Primary Completion: September 30, 2022
• Study Completion: June 30, 2023
• Last Updated: February 26, 2021

Record last verified: 2021-02

Data Sharing

• IPD Sharing: Will not share